Almost 50% of pediatric T-ALL patients harbor mutations in genes encoding protein components of the PI3K-Akt pathway including PIK3CA, AKT, and PTEN, a major negative regulator of the pathway [17, 18]. The gene discussed is PIK3CD; the disease is acute lymphoblastic leukemia.